The effect was reversed by blocking ETA receptor with the selective antagonist BQ-123, meaning that ET-1-mediated ETAR activation triggers protective and antiapoptotic signals on CLL cells. Here, EDNRA is linked to B-cell chronic lymphocytic leukemia.